Opinion

Video

Concluding Remarks: Collaborative Expertise in an Era of Emerging Cancer Therapies

Panelists discuss how there have been many new agents being studied and released at the current time and how the development of these agents is moving at a rapid pace. The adverse effect profiles of newer antibody-drug conjugates create a greater opportunity for pharmacists to be involved in toxicity management.

Video content above has been prompted by the following:

  • Please provide any concluding remarks regarding collaborative expertise in an era of emerging cancer therapies
Related Videos
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video